Please assess the completion status of the following clinical trial:

Trial Title: Optimizing the Management of Postpartum Urinary Retention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age greater than or equal to 18.~2. Vaginal or cesarean delivery at term (37 weeks gestational age or later) of live-born infants.~3. English or Spanish speaking and reading.~Exclusion Criteria:~1. Adults unable to consent.~2. Women under the age of 18.~3. Women who are currently pregnant (All women in the study will have already delivered).~4. Prisoners or detained individuals.~5. Women who chronically use a urinary catheter for another medical condition.~6. Women with a neurological disease with bladder manifestations (examples: Cerebrovascular accidents, Multiple sclerosis, Parkinson disease, cerebral palsy).~7. Women with preeclampsia requiring magnesium treatment for seizure prevention.~8. Women with prior PUR~9. Women on anticholinergic medications.~10. Women who are actively being treated for a UTI.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- GROUP 1 (NonSevere PUR and women without PUR) (Type: NO_INTERVENTION): Women in GROUP 1 will be prospectively observed to characterize their clinical outcomes.
- GROUP 2 (Severe PUR) (Type: EXPERIMENTAL): Women in GROUP 2 will be a randomized to either 3 or 7 days of indwelling catheterization.

Based on this trial design, predict the completion outcome and termination type (if applicable).